WHO has issued two reports about future antibiotics. Here's what the Director-General says, “Never has the threat of antimicrobial resistance been more immediate and the need for solutions more urgent. Numerous initiatives are underway to reduce resistance, but we also need countries and the pharmaceutical industry to step up and contribute with sustainable funding and innovative new medicines.”
WHO studied 60 products in development and concluded that they bring little benefit over existing treatments and very few target the most critical resistant bacteria (Gram-negative bacteria). While some products show progress, it will take years before they reach patients.
No comments:
Post a Comment